Business FDA accepts Eisai’s autoinjector for Alzheimer’s treatment under priority review Published 3 hours ago on 25 January 2026 By NewsAdmin FDA accepts Eisai’s autoinjector for Alzheimer’s treatment under priority review Source link Related Topics: Up Next Yen firms as markets on watch for intervention Don't Miss Explainer-How Singapore’s unique monetary policy works Continue Reading Advertisement You may like Click to comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.